Found 7 matching trials
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL PHASE2 Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation NA Poor graft function (PGF) is a common complication after allogeneic stem ce...
Show More Location
Peking University Institute of Hematology
Learn More & Join Trial
Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP. PHASE2 The probability to achieve CR with R-chemotherapy in patients failing a rit...
Show More Location
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Ematologia
Learn More & Join Trial
Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency PHASE2 Background:
-DOCK8 deficiency is a genetic disorder that affects the immun...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory DLBCL Patients PHASE2 Aim of this trial is to assess the efficacy of new anti-CD20 antibody (GA10...
Show More Location
Ospedale San Bortolo
Learn More & Join Trial
Stem Cell Transplantation in Crohn's Disease PHASE1 Unfortunately, some patients with Crohn's disease (CD) fail to respond to t...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia NA Primary study objective is the evaluation of efficacy of autologous hematop...
Show More Location
Wonkwang University Hospital
Learn More & Join Trial